journal article·2025-08Open access

Gradient Solvent Replacement‐Mediated Formation of High‐Strength Hydrogel‐Forming Microneedle for Long‐Term Drug Delivery

Hui Li, Fengzhen Meng, Chengwei Hu, Zhiyun Wu, Liuzhi Hao, Caijun Sun, Lijing Fang, Fan Pan, Shaoquan Bian, Huipeng Li, Mingjun Li, Bo Liu, Xiaoli Zhao

Advanced Science· Volume 12· Issue 30

Abstract

Abstract The microneedle, a minimally invasive transdermal system, provides a convenient and painless method for drug delivery. Among the various types of microneedles, hydrogel‐forming microneedles (HFMs) demonstrate distinct advantages in terms of high‐dose drug loading and biocompatibility. However, HFMs usually require drying to obtain sufficient puncture strength, which may destroy drug activity and increase storage costs. Herein, a high‐strength HFM patch with pH‐responsiveness for post‐drug loading and long‐term release is developed based on acrylonitrile‐acrylic acid copolymer. The dipole‐dipole and hydrogen bonding interactions formed through gradient solvent replacement are evenly distributed within the cross‐linked network, significantly enhancing the mechanical properties of the hydrogel required for epidermal penetration. The prepared hydrogel exhibits a tensile strength of 26 MPa and a Young's modulus of 407 MPa. The microneedles formed from this hydrogel display a single needle mechanical force of 1.18 N. The post‐loading mode conferred by pH responsiveness allows the drug to be encapsulated in both the tips and the substrate, acting as a reservoir. Once applied to the skin, the microneedle is activated by body fluids to achieve long‐term drug release. Overall, this high‐strength HFM improves the mechanical properties in the hydrated state, making it a promising minimally invasive transdermal delivery platform.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Advancements in Transdermal Drug Delivery · Ocular Surface and Contact Lens · Advanced Drug Delivery Systems

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Institute of Biomedicine and Biotechnology Shenzhen Institute of Advanced Technology Chinese Academy of Sciences Shenzhen 518055 P. R China

Institute of clinical translation and regenerative medicine People's Hospital of Baoan District The Second Affiliated Hospital of Shenzhen University Shenzhen 518101 P. R China

University of Chinese Academy of Sciences Beijing 100049 P. R China

School of Public Health (Shenzhen) Sun Yat‐sen University Shenzhen 518107 P. R China

Hebei Key Laboratory of Biomaterials and Smart Theranostics School of Health Sciences and Biomedical Engineering Hebei University of Technology Tianjin 300130 P. R China

Funding

National Natural Science Foundation of China · Basic and Applied Basic Research Foundation of Guangdong Province · Natural Science Foundation of Hebei Province

References (52)

Show source-provided references
1. 10.1016/j.mattod.2022.10.02510.1016/j.mattod.2022.10.025 ↗
2. 10.1016/j.addr.2012.04.00510.1016/j.addr.2012.04.005 ↗
3. 10.1016/j.jddst.2020.10187710.1016/j.jddst.2020.101877 ↗
4. 10.1007/s12325-019-01101-610.1007/s12325-019-01101-6 ↗
5. 10.1016/j.jconrel.2022.06.02110.1016/j.jconrel.2022.06.021 ↗
6. 10.1002/adma.20230054810.1002/adma.202300548 ↗
7. 10.1002/adma.20210804910.1002/adma.202108049 ↗
8. 10.1002/adma.20230726310.1002/adma.202307263 ↗
9. 10.1002/anie.20242194910.1002/anie.202421949 ↗
10. 10.1038/s44222-023-00141-610.1038/s44222-023-00141-6 ↗
11. 10.1002/advs.20230412410.1002/advs.202304124 ↗
12. 10.1016/j.xcrp.2023.10143010.1016/j.xcrp.2023.101430 ↗
13. 10.1002/advs.20230656010.1002/advs.202306560 ↗
14. 10.1039/D3MH01910A10.1039/D3MH01910A ↗
15. 10.1039/D4TB00659C10.1039/D4TB00659C ↗
16. 10.1002/adfm.20120086410.1002/adfm.201200864 ↗
17. 10.1002/mabi.20200030710.1002/mabi.202000307 ↗
18. 10.1016/j.ejpb.2020.12.00310.1016/j.ejpb.2020.12.003 ↗
19. 10.1002/adhm.20230240610.1002/adhm.202302406 ↗
20. 10.1039/D2TB00126H10.1039/D2TB00126H ↗
21. 10.1016/j.ijpharm.2020.11958010.1016/j.ijpharm.2020.119580 ↗
22. 10.1021/acs.molpharmaceut.4c0006510.1021/acs.molpharmaceut.4c00065 ↗
23. 10.1016/j.biomaterials.2019.11973310.1016/j.biomaterials.2019.119733 ↗
24. 10.1016/j.jiec.2017.10.03010.1016/j.jiec.2017.10.030 ↗
25. 10.1038/s41551-021-00720-110.1038/s41551-021-00720-1 ↗
26. 10.1002/adma.20230546810.1002/adma.202305468 ↗
27. 10.1126/science.aaz669410.1126/science.aaz6694 ↗
28. 10.1021/acs.chemrev.0c0108810.1021/acs.chemrev.0c01088 ↗
29. 10.1038/s41578-024-00672-310.1038/s41578-024-00672-3 ↗
30. 10.1126/sciadv.abp835110.1126/sciadv.abp8351 ↗
31. 10.1146/annurev-chembioeng-101220-08033810.1146/annurev-chembioeng-101220-080338 ↗
32. 10.1002/advs.20240643910.1002/advs.202406439 ↗
33. 10.1016/j.cej.2022.14085410.1016/j.cej.2022.140854 ↗
34. 10.1016/j.jmst.2020.02.03010.1016/j.jmst.2020.02.030 ↗
35. 10.1002/adma.20230199610.1002/adma.202301996 ↗
36. 10.1126/sciadv.adi850510.1126/sciadv.adi8505 ↗
37. 10.1126/sciadv.adh774210.1126/sciadv.adh7742 ↗
38. 10.1002/adfm.20220483710.1002/adfm.202204837 ↗
39. 10.1002/adfm.20160432710.1002/adfm.201604327 ↗
40. 10.1002/marc.20210001010.1002/marc.202100010 ↗
41. 10.1002/adfm.20191019710.1002/adfm.201910197 ↗
42. 10.1002/advs.20220327410.1002/advs.202203274 ↗
43. 10.1016/j.cej.2024.15043710.1016/j.cej.2024.150437 ↗
44. 10.1021/acsami.6b0091210.1021/acsami.6b00912 ↗
45. 10.1002/pol.1983.18021110310.1002/pol.1983.180211103 ↗
46. 10.1016/j.msec.2017.05.14310.1016/j.msec.2017.05.143 ↗
47. 10.1016/j.surfin.2024.10384710.1016/j.surfin.2024.103847 ↗
48. 10.1002/smll.20190591010.1002/smll.201905910 ↗
49. 10.1002/sstr.20240001410.1002/sstr.202400014 ↗
50. 10.1111/srt.1339610.1111/srt.13396 ↗
51. 10.1016/j.jconrel.2022.04.04310.1016/j.jconrel.2022.04.043 ↗
52. 10.3390/biomedicines1108211910.3390/biomedicines11082119 ↗